Presentation is loading. Please wait.

Presentation is loading. Please wait.

Forest plot illustrating the risk ratio of myocardial infarction

Published byAlessandra Estrela Modified over 5 years ago

Similar presentations

Presentation on theme: "Forest plot illustrating the risk ratio of myocardial infarction"— Presentation transcript:

1 Forest plot illustrating the risk ratio of myocardial infarction
Forest plot illustrating the risk ratio of myocardial infarction. AF, atrial fibrillation; DOAC, advent of direct oral anticoagulants; PCI, percutaneous coronary interventions; VKAs, vitamin K antagonists. Forest plot illustrating the risk ratio of myocardial infarction. AF, atrial fibrillation; DOAC, advent of direct oral anticoagulants; PCI, percutaneous coronary interventions; VKAs, vitamin K antagonists. Natale Daniele Brunetti et al. Open Heart 2018;5:e000785 ©2018 by British Cardiovascular Society

Download ppt "Forest plot illustrating the risk ratio of myocardial infarction"

Similar presentations

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.
Safety and Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists: Pilot Implementation of a Near‐Real‐Time Monitoring Program in Italy.

Safety and Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists: Pilot Implementation of a Near‐Real‐Time Monitoring Program in Italy.
by Kueiyu Joshua Lin, Daniel E. Singer, Robert J

by Kueiyu Joshua Lin, Daniel E. Singer, Robert J
Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.

Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.
Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal  Gregory.

Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal  Gregory.
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Laurent Macle, MD, John Cairns, MD, Kori.

2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Laurent Macle, MD, John Cairns, MD, Kori.
Barriers to Oral Anticoagulant Use for Stroke Prevention in AF

Barriers to Oral Anticoagulant Use for Stroke Prevention in AF
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)

Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)
FAERS death cases (all years) for NOACs versus warfarin.

FAERS death cases (all years) for NOACs versus warfarin.
Forest plot of the HRs for DOACs vs warfarin for (A) new or recurrent VTE and (B) major bleeding based on the published subanalyses of the patients with.

Forest plot of the HRs for DOACs vs warfarin for (A) new or recurrent VTE and (B) major bleeding based on the published subanalyses of the patients with.
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);

Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

P2Y12 blockade versus placebo; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.
Figure 2 Absolute difference in seasonal peak

Figure 2 Absolute difference in seasonal peak
Coronary revascularisation rate (total 5

Coronary revascularisation rate (total 5
Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.
David J.A. Jenkins et al. JACC 2018;71:

David J.A. Jenkins et al. JACC 2018;71:
The recommended approach to patients with chronic obstructive pulmonary disease (COPD) presenting with dyspnoea. The recommended approach to patients with.

The recommended approach to patients with chronic obstructive pulmonary disease (COPD) presenting with dyspnoea. The recommended approach to patients with.
Tornado diagram of one-way deterministic sensitivity analysis.

Tornado diagram of one-way deterministic sensitivity analysis.

Similar presentations

Ads by Google